This article has been updated to include a response from Becton Dickinson.

NEW YORK (360DX) – The US Food and Drug Administration today issued a warning letter to Becton Dickinson, outlining a number of violations of federal law related to the company's Vacutainer blood collection tubes, including changes it made to the tubes and its failure to investigate complaints about their performance.

To read the full story....

Register for Free.

...and receive Daily News bulletins.

Already have a 360Dx or GenomeWeb account?
Login Now.